Cancer News and Research

Latest Cancer News and Research

Aspirin associated with reduced risk of serious ovarian cancer

New research shows that women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serious ovarian cancer—an aggressive carcinoma affecting the surface of the ovary.

10 Oct 2012

MRI method ‘cuts breast cancer false‑positives’

Assessing apparent diffusion coefficients during dynamic contrast-enhanced magnetic resonance imaging may reduce the number of avoidable false‑positive breast cancer results and unnecessary biopsies, show findings published in Radiology.

9 Oct 2012

Johns Hopkins joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Johns Hopkins University School of Medicine in Baltimore, MD has joined the Company's ongoing Phase I/II trial in newly diagnosed elderly patients with acute myeloid leukemia (AML).

9 Oct 2012

Coffee consumption activates bowel motility after elective colonic surgery

Patients who drank coffee, rather than water, after bowel surgery to remove a part of their colon experienced a quicker return to bowel movements and tolerance of solid food.

9 Oct 2012

Roundup: Texas doctors turn to politics; Reviewing Calif. legislative action on health

The state's largest doctors association says it can't remember a time when so many Texas physicians held elected office in Texas. But sometimes their medical backgrounds put them at odds with members of their own party.

9 Oct 2012

Viewpoints: Romney's views on health care still mysterious; Treating the dying patient

Mitt Romney may know more about healthcare than any other presidential nominee in memory. As governor of Massachusetts, he dove deeply into the subject while creating the most far-reaching state health plan in the country.

9 Oct 2012

Study sheds light on fundamental cellular process

Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes-and revealing new clues as to what happens when this process goes awry.

9 Oct 2012

Study examines trends in HIV mortality

Overall death rates due to human immunodeficiency virus (HIV) infection declined over time between 1993 and 2007 for most men and women by race/ethnicity and educational levels, with the largest absolute decreases for nonwhites, but rates remain high among blacks, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

9 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

Endotrophin may serve as novel therapeutic target for breast cancer

Fat cells (adipocytes) surround breast tumors and contribute to tumor growth by expressing factors that aid oncogenesis. Col6 is a protein that is highly expressed in adipocytes and its expression is further increased in both obesity and in breast cancer cells.

9 Oct 2012

HPV status predicts oropharyngeal cancer irradiation response

Human papillomavirus-positive head and neck cancer is more sensitive to the initial effects of radiation therapy than HPV-negative head and neck cancer, suggest study findings.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

Trellis, OMT enter collaboration to generate human antibodies

Trellis Bioscience LLC and Open Monoclonal Technology, Inc. today announced a new collaboration where the companies will join forces to generate human antibodies against therapeutic targets identified by Trellis and its partners using OMT's OmniRat platform.

8 Oct 2012

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract and a Phase 2 option from the National Cancer Institute (NCI) valued up to $1,683,503.

8 Oct 2012

Scientists discover process by which vitamin B12 is made in cells

In a development that may lead to new drugs to treat cancer, scientists at the University of Kent have discovered the process by which a key vitamin (B12) is made in cells.

8 Oct 2012

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).

8 Oct 2012

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

GTx, Inc. announced today there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of life in middle aged and elderly cancer patients.

8 Oct 2012

New device may restore voice in patients with laryngeal cancer

Patients who have lost their voice box through disease such as throat cancer may be able to speak immediately after a procedure to create a small opening at the throat.

8 Oct 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a Phase II clinical trial conducted by investigators at Rational Therapeutics and the MemorialCare Todd Cancer Institute and published in the October issue of Anticancer Research.

8 Oct 2012

Patient navigation services can reduce dangerous delays in identification of breast cancer

Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services.

8 Oct 2012

Cancer News and Research

Latest Cancer News and Research

Aspirin associated with reduced risk of serious ovarian cancer

MRI method ‘cuts breast cancer false‑positives’

Johns Hopkins joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Coffee consumption activates bowel motility after elective colonic surgery

Roundup: Texas doctors turn to politics; Reviewing Calif. legislative action on health

Viewpoints: Romney's views on health care still mysterious; Treating the dying patient

Study sheds light on fundamental cellular process

Study examines trends in HIV mortality

New blood test can read genetic changes in prostate cancer

Endotrophin may serve as novel therapeutic target for breast cancer

HPV status predicts oropharyngeal cancer irradiation response

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

Trellis, OMT enter collaboration to generate human antibodies

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Scientists discover process by which vitamin B12 is made in cells

USPTO grants five-year extension to Spectrum's FOLOTYN patent

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

New device may restore voice in patients with laryngeal cancer

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Patient navigation services can reduce dangerous delays in identification of breast cancer

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in